HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Okuyama Selected Research

Hyperlipidemias (Hyperlipidemia)

10/2001Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus.
1/2000Clinicopathological evaluation in non-episode biopsies of renal transplant allograft.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Okuyama Research Topics

Disease

10Neoplasms (Cancer)
11/2001 - 01/2000
5Prostatic Neoplasms (Prostate Cancer)
12/2001 - 10/2000
5Neoplasm Metastasis (Metastasis)
05/2001 - 06/2000
5Carcinoma (Carcinomatosis)
03/2001 - 02/2000
3Urinary Bladder Neoplasms (Bladder Cancer)
05/2001 - 01/2001
3Prostatic Intraepithelial Neoplasia
03/2001 - 02/2000
2Hypogonadism (Hypergonadotropic Hypogonadism)
05/2005 - 11/2002
2IGA Glomerulonephritis (IGA Nephropathy)
06/2004 - 05/2000
2Proteinuria
01/2004 - 01/2001
2Azoospermia
07/2002 - 01/2002
2Hyperlipidemias (Hyperlipidemia)
10/2001 - 01/2000
2Urolithiasis
09/2001 - 11/2000
2Lymphatic Metastasis
01/2001 - 12/2000
2Transitional Cell Carcinoma
01/2001 - 12/2000
2Infections
11/2000 - 01/2000
1Lupus Nephritis
02/2018
1Sertoli Cell-Only Syndrome
08/2005
1Atherosclerosis
01/2004
1Chronic Kidney Failure (Chronic Renal Failure)
11/2002
1Testicular Neoplasms (Testicular Cancer)
11/2001
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
11/2001
1Small Cell Carcinoma
11/2001
1Hypercholesterolemia
10/2001
1Hypertriglyceridemia
10/2001
1Myeloid Leukemia (Leukemia, Myelocytic)
08/2001
1Hematologic Neoplasms (Hematological Malignancy)
08/2001
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2001
1Sarcoglycanopathies
07/2001
1Walker-Warburg Syndrome
07/2001
1type 2C Limb-girdle muscular dystrophy
07/2001
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
07/2001
1Neuromuscular Diseases (Neuromuscular Disease)
07/2001
1Sarcoma 180
04/2001
1Colonic Neoplasms (Colon Cancer)
04/2001
1Body Weight (Weight, Body)
03/2001
1Convalescence
02/2001

Drug/Important Bio-Agent (IBA)

4Hormones (Hormone)IBA
11/2002 - 12/2000
3Proteins (Proteins, Gene)FDA Link
01/2004 - 03/2000
3Messenger RNA (mRNA)IBA
11/2001 - 03/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2018 - 01/2001
2Tacrolimus (Prograf)FDA LinkGeneric
02/2018 - 01/2001
2LipidsIBA
01/2004 - 01/2000
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
12/2001 - 10/2000
2GlucocorticoidsIBA
11/2001 - 12/2000
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2001 - 12/2000
2Cisplatin (Platino)FDA LinkGeneric
11/2001 - 01/2001
2Tumor Biomarkers (Tumor Markers)IBA
11/2001 - 01/2001
2Calcium OxalateIBA
09/2001 - 11/2000
2SI 27IBA
08/2001 - 04/2001
2Matrix Metalloproteinase InhibitorsIBA
08/2001 - 04/2001
2DNA (Deoxyribonucleic Acid)IBA
08/2001 - 03/2001
2Peptide Hydrolases (Proteases)FDA Link
04/2001 - 01/2000
2Prostate-Specific Antigen (Semenogelase)IBA
01/2001 - 12/2000
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
02/2018
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
08/2005
1Inhibins (Inhibin)IBA
08/2005
1Stem Cell FactorIBA
08/2005
1Testosterone (Sustanon)FDA Link
05/2005
1HLA Antigens (Human Leukocyte Antigens)IBA
07/2002
1HLA-DR Antigens (HLA-DR)IBA
07/2002
1Cadherins (E-Cadherin)IBA
12/2001
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
11/2001
1AndrogensIBA
11/2001
1NF-kappa B (NF-kB)IBA
11/2001
1HLA-DR4 Antigen (HLA DR4 Antigen)IBA
11/2001
1HLA-DRB1 Chains (HLA DRB1)IBA
11/2001
1CholesterolIBA
10/2001
1Triglycerides (Triacylglycerol)IBA
10/2001
1Simvastatin (Zocor)FDA LinkGeneric
10/2001
1CitratesIBA
09/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2001
1Caspase 8 (Caspase-8)IBA
08/2001
1Cytotoxins (Cytolysins)IBA
08/2001
1Annexin A5IBA
08/2001
1NF-KappaB Inhibitor alphaIBA
08/2001
1Dystroglycans (Dystroglycan)IBA
07/2001
1pirarubicinIBA
05/2001
1L- N- (N- hydroxy- 2- isobutylsuccinamoyl)seryl- L- valineIBA
04/2001
1ebselenIBA
04/2001
1BradykininIBA
04/2001
13-nitrotyrosineIBA
04/2001
1Peroxynitrous Acid (Peroxynitrite)IBA
04/2001
1Uric Acid (Urate)IBA
04/2001
1Matrix Metalloproteinases (MMPs)IBA
04/2001
1UracilIBA
01/2001
1CreatinineIBA
01/2001
1EstramustineFDA Link
01/2001
1TegafurIBA
01/2001

Therapy/Procedure

6Kidney Transplantation
06/2004 - 01/2000
3Therapeutics
02/2018 - 01/2000
2Lasers (Laser)
03/2001 - 09/2000
2Nephrectomy
02/2001 - 06/2000
1Remission Induction
02/2018
1Herniorrhaphy
01/2002
1Cystectomy
11/2001
1Intravesical Administration
05/2001
1Drug Therapy (Chemotherapy)
05/2001
1Aftercare (After-Treatment)
03/2001
1Operative Time
02/2001
1Transplantation
01/2001